Abstract:
An electro-hydraulic actuator (EHA) includes a hydraulic circuit having a plurality of pressure compensated flow control valves for limiting the maximum flow rate through the fluid conduits regardless of the loads imparted on the actuator. In one embodiment of the EHA, a plurality of combination manual override/thermal expansion valves that simplify the manufacture of the EHA.
Abstract:
The invention relates to a novel method of inexpensively synthesizing large quantities of an essentially pure, biologically active, glycosylated Dkk protein, including mammalian and human Dkk proteins (e.g., human Dkk1). The invention further relates to the synthetically produced essentially purified, glycosylated and biologically active Dkk protein, and the characteristics of the protein.
Abstract:
A hybrid prolapse repair material comprising a polypropylene and a graft body attached together. Attachments are provided for detachably attaching a repair material to a needle. A needle and a system for using the needle are contemplated to get repair material closer to the ischial spine. Graft to arm attachment concepts are taught to couple a mesh to a graft body. Additionally, a hysterectomy tool is provided to allow a surgeon to track vital organs.
Abstract:
Improved methods and apparatuses for treatment of pelvic organ prolapse are provided. A specialized sacral colpopexy mesh having a mesh cylinder attached to a first end of a main mesh is disclosed, and a method for use thereof in abdominal sacral colpopexy. A novel connector that is used to attach a mesh to the needle, including gripping features that improve the grip and allowing for easier connection and disconnection is disclosed, as well as a novel method and apparatus for connecting a mesh to a needle.
Abstract:
Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes inserting an intramural crossing device into the vascular lumen, positioning at least the distal tip of the crossing device in the vascular wall, advancing an orienting device over the crossing device such that an orienting element of the orienting device resides in the vascular wall, inserting a re-entry device, and re-entering the true vascular lumen.
Abstract:
Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes providing a first intravascular device having a distal portion with a concave side, inserting the first device into the vascular lumen, positioning the distal portion in the vascular wall, and orienting the concave side of the distal portion toward the vascular lumen.
Abstract:
The present invention is directed to compound of formula (A): wherein R1 is selected from (a) alkyl, alkenyl, alkynyl, cycloalkyl, aryl, and heteroaryl, or (b) CN and —C(NR10R11)═N—R12, R2 is selected from the group consisting of alkyl, alkenyl, alkynyl, cycloalkyl, aryl and heteroaryl, R3-R12 are as described within the specification, and A is O, NR9 or S, or a prodrug, a pharmaceutically acceptable salt or a pharmaceutically active metabolite thereof, provided that R1 is not alkyl when R2 is pyridine, provided that at least one of R3-R8 is not H or F when A is O, R1 is (b) and R2 is a phenyl ring, a phenyl ring substituted at the para position with halo, —CN, —OCH3, —CF3 or —CO2CH3, a quinoline or an ethylene substituted with a phenyl ring or a 3,4-methylenedioxyphenyl moiety, provided that R4 is not methyl when R3 and R5-R8 are H, A is O, R1 is (b) and R2 is 4-chlorophenyl, and provided that R6 is not Cl when R3-R5 and R7-R8 are H, R1 is CN and R2 is phenyl. This invention is also directed to methods of using the same for treating HIV infections, or AIDS, or preventing replication.
Abstract:
Systems and methods are presented for facilitating entertainment media listings using unique user identifiers. In some embodiments, a computer-implemented method is presented. The method may include accessing a unique user identifier of a user, the unique user identifier associated with at least one form of entertainment media, the unique user identifier including a user history of at least one form of the entertainment media accessed by the user. The method may also include transmitting first information for displaying an offer to conduct a consumer transaction of a product associated with the at least one form of entertainment media, wherein displaying the offer is based on the user history within the accessed unique user identifier.
Abstract:
Methods, systems, and apparatus for providing assistance to a user of a mobile application are described. A request for assistance from the user is detected and a request is issued to a remote device for establishment of a remote assistance session. Information describing a state of the mobile device is periodically transmitted to the remote device and one or more commands may be received from the remote device. The commands may be executed on the mobile device.
Abstract:
The present invention is directed to compound of formula (A): wherein R1 is selected from (a) alkyl, alkenyl, alkynyl, cycloalkyl, aryl, and heteroaryl, or (b) CN and —C(NR10R11)═N—R12, R2 is selected from the group consisting of alkyl, alkenyl, alkynyl, cycloalkyl, aryl and heteroaryl, R3-R12 are as described within the specification, and A is O, NR9 or S, or a prodrug, a pharmaceutically acceptable salt or a pharmaceutically active metabolite thereof, provided that R1 is not alkyl when R2 is pyridine, provided that at least one of R3-R8 is not H or F when A is O, R1 is (b) and R2 is a phenyl ring, a phenyl ring substituted at the para position with halo, —CN, —OCH3, —CF3 or —CO2CH3, a quinoline or an ethylene substituted with a phenyl ring or a 3,4-methylenedioxyphenyl moiety, provided that R4 is not methyl when R3 and R5-R8 are H, A is O, R1 is (b) and R2 is 4-chlorophenyl, and provided that R6 is not Cl when R3-R5 and R7-R8 are H, R1 is CN and R2 is phenyl. This invention is also directed to methods of using the same for treating HIV infections, or AIDS, or preventing replication.